PAK FAH YEOW INTERNATIONAL LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.06 HKD | +2.49% |
|
+0.49% | +16.38% |
| Sales 2022 | 148M 18.87M | Sales 2023 | 260M 33.16M | Capitalization | 552M 70.46M |
|---|---|---|---|---|---|
| Net income 2022 | 30M 3.83M | Net income 2023 | 105M 13.41M | EV / Sales 2022 | 1.4 x |
| Net cash position 2022 | 179M 22.85M | Net cash position 2023 | 277M 35.43M | EV / Sales 2023 | 1.06 x |
| P/E ratio 2022 |
12.9
x | P/E ratio 2023 |
5.25
x | Employees | 102 |
| Yield 2022 |
4.92% | Yield 2023 |
3.84% | Free-Float | 38.51% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.49% | ||
| 1 week | +0.49% | ||
| Current month | -1.44% | ||
| 1 month | -5.07% | ||
| 3 months | +18.39% | ||
| 6 months | +27.16% | ||
| Current year | +16.38% |
1 week
1.98
2.08
1 month
1.982.20
Current year
1.702.20
1 year
1.242.20
3 years
0.922.20
5 years
0.923.08
10 years
0.924.50
| Managers | Title | Age | Since |
|---|---|---|---|
Wee Sean Gan
CEO | Chief Executive Officer | 77 | 91-10-07 |
Hung Kei Tsang
DFI | Director of Finance/CFO | 53 | 05-04-30 |
Fock Wai Gan
BRD | Director/Board Member | 62 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fock Wai Gan
BRD | Director/Board Member | 62 | - |
Man Chiu Leung
BRD | Director/Board Member | 75 | 06-06-30 |
Wee Sean Gan
CEO | Chief Executive Officer | 77 | 91-10-07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 2.06 | +2.49% | 69 500 |
| 24-04-24 | 2.01 | -1.47% | 97,500 |
| 24-04-23 | 2.04 | +0.49% | 0 |
| 24-04-22 | 2.03 | -0.98% | 56,000 |
| 24-04-19 | 2.05 | 0.00% | 0 |
Delayed Quote Hong Kong S.E., April 25, 2024 at 02:12 am EDT
More quotes
Pak Fah Yeow International Ltd is an investment holding company principally engaged in the manufacture and sale of healthcare products. The Company operates through three segments. The Healthcare segment is engaged in the manufacture and sales of healthcare products under the brand names of Hoe Hin products. The Property Investment segment is engaged in the investment in commercial, office, industrial and residential properties. The Treasury Investment segment is engaged in the equity and debt securities, mutual funds and dual currency investments businesses.
Sector
Pharmaceuticals
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +16.38% | 79.97M | |
| +19.82% | 42.78B | |
| +18.59% | 22.25B | |
| +13.12% | 14.39B | |
| +12.14% | 13.55B | |
| +35.51% | 11.27B | |
| -9.80% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.29% | 5.01B |
- Stock Market
- Equities
- 239 Stock
